These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

909 related items for PubMed ID: 16679099

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery.
    Goei D, Schouten O, Boersma E, Welten GM, Dunkelgrun M, Lindemans J, van Gestel YR, Hoeks SE, Bax JJ, Poldermans D.
    Am J Cardiol; 2008 Jan 01; 101(1):122-6. PubMed ID: 18157978
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
    Hong SN, Ahn Y, Yoon NS, Lee KH, Kim YS, Hwang SH, Lee SR, Kim KH, Park HW, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.
    Am J Cardiol; 2007 Apr 15; 99(8):1051-4. PubMed ID: 17437726
    [Abstract] [Full Text] [Related]

  • 6. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
    Feringa HH, Bax JJ, Elhendy A, de Jonge R, Lindemans J, Schouten O, van den Meiracker AH, Boersma E, Schinkel AF, Kertai MD, van Sambeek MR, Poldermans D.
    Am J Cardiol; 2006 Jul 01; 98(1):111-5. PubMed ID: 16784932
    [Abstract] [Full Text] [Related]

  • 7. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
    Jarai R, Fellner B, Haoula D, Jordanova N, Heinz G, Karth GD, Huber K, Geppert A.
    Crit Care Med; 2009 Jun 01; 37(6):1837-44. PubMed ID: 19384228
    [Abstract] [Full Text] [Related]

  • 8. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.
    J Heart Lung Transplant; 2007 May 01; 26(5):516-21. PubMed ID: 17449423
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
    Wang AY, Lam CW, Wang M, Chan IH, Lui SF, Zhang Y, Sanderson JE.
    Nephrol Dial Transplant; 2009 Jun 01; 24(6):1962-9. PubMed ID: 19237403
    [Abstract] [Full Text] [Related]

  • 12. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M, Bartunek, Claeys G, Manoharan G, Beckers JF, Ide L.
    Clin Biochem; 2006 Jun 01; 39(6):640-5. PubMed ID: 16516185
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D.
    Nephrol Dial Transplant; 2008 Apr 01; 23(4):1370-7. PubMed ID: 18089624
    [Abstract] [Full Text] [Related]

  • 14. B-type natriuretic peptide infusions in acute myocardial infarction.
    Hillock RJ, Frampton CM, Yandle TG, Troughton RW, Lainchbury JG, Richards AM.
    Heart; 2008 May 01; 94(5):617-22. PubMed ID: 17639095
    [Abstract] [Full Text] [Related]

  • 15. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC.
    Rev Port Cardiol; 2004 Dec 01; 23(12):1557-82. PubMed ID: 15732658
    [Abstract] [Full Text] [Related]

  • 16. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, Lui SF, Sanderson JE.
    J Am Soc Nephrol; 2007 Jan 01; 18(1):321-30. PubMed ID: 17167121
    [Abstract] [Full Text] [Related]

  • 17. Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.
    de Lemos JA, McGuire DK, Khera A, Das SR, Murphy SA, Omland T, Drazner MH.
    Am Heart J; 2009 Apr 01; 157(4):746-53.e2. PubMed ID: 19332205
    [Abstract] [Full Text] [Related]

  • 18. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
    Steen H, Futterer S, Merten C, Jünger C, Katus HA, Giannitsis E.
    J Cardiovasc Magn Reson; 2007 Apr 01; 9(5):749-58. PubMed ID: 17891611
    [Abstract] [Full Text] [Related]

  • 19. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
    Andreassen AK, Wergeland R, Simonsen S, Geiran O, Guevara C, Ueland T.
    Am J Cardiol; 2006 Aug 15; 98(4):525-9. PubMed ID: 16893710
    [Abstract] [Full Text] [Related]

  • 20. Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population.
    Kotanidou A, Karsaliakos P, Tzanela M, Mavrou I, Kopterides P, Papadomichelakis E, Theodorakopoulou M, Botoula E, Tsangaris I, Lignos M, Ikonomidis I, Ilias I, Armaganidis A, Orfanos SE, Dimopoulou I.
    Shock; 2009 Apr 15; 31(4):342-7. PubMed ID: 18791494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.